The federal Food & Drug Administration’s top drug approval official is the latest apparatchik to come under fire, the Wall Street Journal reports.
The inspector general of the Dept. of Health and Human Services is investigating a conflict-of-interest allegation against Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research.
The news broke just a day after the FDA’s top devices official, Daniel Schultz, told his soon-to-be-ex-underlings he was stepping down as head of the Center for Devices and Radiological Health.